The Current Ratio as of December 2024 (TTM) for Aeterna Zentaris Inc. (AEZS) is 5.94

According to Aeterna Zentaris Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.94. This represents a change of -32.35% compared to the average of 8.78 of the last 4 quarters.

Aeterna Zentaris Inc. (AEZS) Historical Current Ratio (quarterly & annually)

How has AEZS Current Ratio performed in the past?

The mean historical Current Ratio of Aeterna Zentaris Inc. over the last ten years is 5.38. The current 5.94 Current Ratio has changed 10.94% with respect to the historical average. Over the past ten years (40 quarters), AEZS's Current Ratio was at its highest in in the June 2021 quarter at 16.43. The Current Ratio was at its lowest in in the December 2017 quarter at 1.63.

Aeterna Zentaris Inc. (AEZS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aeterna Zentaris Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aeterna Zentaris Inc. (AEZS) Average Current Ratio

How has AEZS Current Ratio performed in the past?

The current Current Ratio of Aeterna Zentaris Inc. (AEZS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Aeterna Zentaris Inc. (AEZS) Current Ratio vs. Peers

How is AEZS’s Current Ratio compared to its peers?

Aeterna Zentaris Inc.’s Current Ratio is less than Pulmatrix, Inc. (19.40), greater than Onconova Therapeutics, Inc. (1.07), greater than Catalyst Biosciences, Inc. (3.72), greater than Bio-Path Holdings, Inc. (0.86), greater than Moleculin Biotech, Inc. (2.08), less than Adial Pharmaceuticals, Inc. (6.78), less than Diffusion Pharmaceuticals Inc. (15.04), greater than Tonix Pharmaceuticals Holding Corp. (3.33), less than Jaguar Health, Inc. (0), greater than Acasti Pharma Inc. (1.84), less than iBio, Inc. (7.86), greater than TransCode Therapeutics, Inc. (3.37), greater than Aditxt, Inc. (1.58), greater than Reviva Pharmaceuticals Holdings, Inc. (0.09), greater than Avenue Therapeutics, Inc. (0.39), greater than null (2.70),

Build a custom stock screener for Aeterna Zentaris Inc. (AEZS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aeterna Zentaris Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aeterna Zentaris Inc. (AEZS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aeterna Zentaris Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.